SBFM
Sunshine Biopharma, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$1.14
+2.70%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-54.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 11, 2026 | NATAN DAVID · director | A-Award | 58,300 | $0.00 |
| Apr 14, 2026 | NATAN DAVID · director | A-Award | 100,000 | $0.00 |
| Mar 5, 2024 | Slilaty Steve N. · director, 10 percent owner, officer: Chief Executive Officer | Purchase | 100,000 | $0.10 |
| Feb 12, 2024 | Slilaty Steve N. · director, 10 percent owner, officer: Chief Executive Officer | Purchase | 20,000 | $0.10 |
| Dec 2, 2022 | Sebaaly Camille · officer: CFO/Secretary | Purchase | 30,000 | $0.76 |
| Jun 6, 2022 | Sebaaly Camille · officer: CFO/Secretary | Purchase | 25,000 | $1.22 |
| Feb 16, 2021 | Sebaaly Camille · director, officer: CFO/Secretary | A-Award | 20,000,000 | $0.00 |
| Feb 16, 2021 | Slilaty Steve N. · director, officer: Chief Executive Officer | A-Award | 20,000,000 | $0.00 |
| Feb 16, 2021 | MERZOUKI ABDERRAZZAK · director, officer: Chief Operating Officer | A-Award | 20,000,000 | $0.00 |
| Jul 15, 2020 | Sebaaly Camille · director, officer: CFO/Secretary | A-Award | 550,000 | $0.00 |
| Jul 15, 2020 | Sebaaly Camille · director, officer: CFO/Secretary | A-Award | 323,673 | $0.00 |
| Jul 15, 2020 | Sebaaly Camille · director, officer: CFO/Secretary | A-Award | 1,300,000 | $0.00 |
| Jul 15, 2020 | Sebaaly Camille · director, officer: CFO/Secretary | A-Award | 1,100,000 | $0.00 |
| Jul 13, 2020 | MERZOUKI ABDERRAZZAK · director, officer: Chief Operating Officer | A-Award | 1,100,000 | $0.00 |
| Jul 13, 2020 | MERZOUKI ABDERRAZZAK · director, officer: Chief Operating Officer | A-Award | 1,300,000 | $0.00 |
| Jul 10, 2020 | Slilaty Steve N. · director, officer: Chief Executive Officer | A-Award | 1,300,000 | $0.00 |
| Jul 10, 2020 | Slilaty Steve N. · director, officer: Chief Executive Officer | A-Award | 1,100,000 | $0.00 |
| Jun 25, 2020 | Slilaty Steve N. · director, officer: Chief Executive Officer | A-Award | 500,000 | $0.10 |
| Oct 7, 2019 | MERZOUKI ABDERRAZZAK · director, officer: Chief Operating Officer | A-Award | 27,000,000 | $0.00 |
| Oct 7, 2019 | MERZOUKI ABDERRAZZAK · director, officer: Chief Operating Officer | A-Award | 13,000,000 | $0.00 |
| Oct 7, 2019 | MERZOUKI ABDERRAZZAK · director, officer: Chief Operating Officer | A-Award | 38,000,000 | $0.00 |
| Oct 4, 2019 | MERZOUKI ABDERRAZZAK · director, officer: Chief Operating Officer | A-Award | 28,000,000 | $0.00 |
| Oct 4, 2019 | MERZOUKI ABDERRAZZAK · director, officer: Chief Operating Officer | A-Award | 14,000,000 | $0.00 |
| Oct 4, 2019 | MERZOUKI ABDERRAZZAK · director, officer: Chief Operating Officer | A-Award | 12,000,000 | $0.00 |
| Sep 23, 2019 | Sebaaly Camille · director, 10 percent owner, officer: Secretary | A-Award | 11,000,000 | $0.00 |
| Sep 23, 2019 | Sebaaly Camille · director, 10 percent owner, officer: Secretary | A-Award | 13,000,000 | $0.00 |
| Sep 23, 2019 | Slilaty Steve N. · director, 10 percent owner, officer: Chief Executive Officer | A-Award | 13,000,000 | $0.00 |
| Sep 14, 2018 | Slilaty Steve N. · director, officer: Chief Executive Officer | A-Award | 38,000,000 | $0.00 |
| Sep 14, 2018 | Sebaaly Camille · director, officer: Secretary | A-Award | 38,000,000 | $0.00 |
| Sep 14, 2018 | MERZOUKI ABDERRAZZAK · director, officer: Chief Operating Officer | A-Award | 38,000,000 | $0.00 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 11, 2026